Organization
Institute of Urgent and Recovery Surgery, Donetsk, Ukraine
3 abstracts
Abstract
ANTIBODY TO ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) LEVEL DETERMINES CLINICAL RESPONSE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) TO DMARD THERAPYOrg: Laboratory for Fundamental Research, Cardiosurgery Dept., Institute of Urgent and Recovery Surgery, Donetsk, Ukraine, Chair of Family Medicine, Immunology Dept,
Abstract
ALLOGENIC STEM CELL TRANSPLANTATION DELAYS STRUCTURE DEGRADATION RATE IN ADJUVANT ARTHRITIS RATSOrg: Laboratory of Fundamental Research, Laboratory of Tissue Engineering, Institute of Urgent and Recovery Surgery, Donetsk, Ukraine,
Abstract
A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 1 STUDY COMPARING THE PHARMACOKINETICS, SAFETY AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 54 WEEK RESULTS FROM THE PLANETAS STUDY Org: Inha Univ. Hospital, Incheon, Korea, Republic Of, Linea Corporis, Warszawa, Wojewodzki Szpital Zespolony w Elblagu, Elbląg, Poland, Institute of Urgent and Recovery Surgery, Donetsk, Ukraine, Univ. Hospital St. Marina, Varna, Bulgaria,